US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 18.500
- +1.990+12.05%
Close Nov 22 16:00 ET
- 18.500
- 0.0000.00%
Post 20:01 ET
618.22MMarket Cap-11191P/E (TTM)
19.000High16.750Low127.31KVolume16.750Open16.510Pre Close2.25MTurnover1.25%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High2.28P/B188.70MFloat Cap15.31052wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM13.63%Amplitude15.310Historical Low17.662Avg Price1Lot Size
MBX Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expense | 79.19%19.61M | 40.34%35.31M | 9.99M | 10.95M | 25.16M |
| Selling and administrative expenses | 53.04%2.87M | 80.05%6.78M | --2.26M | --1.87M | --3.76M |
| -General and administrative expense | 53.04%2.87M | 80.05%6.78M | --2.26M | --1.87M | --3.76M |
| Research and development costs | 84.58%16.75M | 33.36%28.53M | --7.73M | --9.07M | --21.4M |
| Operating profit | -79.19%-19.61M | -40.34%-35.31M | -9.99M | -10.95M | -25.16M |
| Net non-operating interest income expense | 87.74%1.47M | 137,500.00%2.75M | 1.15M | 783K | -2K |
| Non-operating interest income | 87.74%1.47M | 638.71%2.75M | --1.15M | --783K | --372K |
| Non-operating interest expense | ---- | --0 | ---- | ---- | --374K |
| Other net income (expense) | -972K | ||||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---73K |
| Special income (charges) | ---- | --0 | ---- | ---- | ---899K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | --899K |
| Income before tax | -78.53%-18.14M | -24.60%-32.56M | -8.84M | -10.16M | -26.14M |
| Income tax | |||||
| Net income | -78.53%-18.14M | -24.60%-32.56M | -8.84M | -10.16M | -26.14M |
| Net income continuous Operations | -78.53%-18.14M | -24.60%-32.56M | ---8.84M | ---10.16M | ---26.14M |
| Minority interest income | |||||
| Net income attributable to the parent company | -78.53%-18.14M | -24.60%-32.56M | -8.84M | -10.16M | -26.14M |
| Preferred stock dividends | |||||
| Other preferred stock dividends | |||||
| Net income attributable to common stockholders | -78.53%-18.14M | -24.60%-32.56M | -8.84M | -10.16M | -26.14M |
| Basic earnings per share | -771.42%-2.78 | -24.60%-1.0223 | -0.2776 | -0.319 | -0.8205 |
| Diluted earnings per share | -771.42%-2.78 | -24.60%-1.0223 | -0.2776 | -0.319 | -0.8205 |
| Dividend per share | |||||
| Currency Unit | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
